| Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B S Menne, DB Tumas, KH Liu, L Thampi, D AlDeghaither, BH Baldwin, ... Journal of hepatology 62 (6), 1237-1245, 2015 | 244 | 2015 |
| Mechanisms of action of therapeutic antibodies for cancer JM Redman, EM Hill, D AlDeghaither, LM Weiner Molecular immunology 67 (2), 28-45, 2015 | 232 | 2015 |
| Enhancing antibody-dependent cell-mediated cytotoxicity: a strategy for improving antibody-based immunotherapy D Zahavi, D AlDeghaither, A O’Connell, LM Weiner Antibody Therapeutics 1 (1), 7-12, 2018 | 140 | 2018 |
| The development of immunoconjugates for targeted cancer therapy BG Smaglo, D Aldeghaither, LM Weiner Nature Reviews Clinical Oncology 11 (11), 637-648, 2014 | 112 | 2014 |
| Beyond peptides and mAbs—current status and future perspectives for biotherapeutics with novel constructs D AlDeghaither, BG Smaglo, LM Weiner The Journal of Clinical Pharmacology 55 (S3), S4-S20, 2015 | 87 | 2015 |
| A mechanism of resistance to antibody-targeted immune attack DS Aldeghaither, DJ Zahavi, JC Murray, EJ Fertig, GT Graham, YW Zhang, ... Cancer immunology research 7 (2), 230-243, 2019 | 58 | 2019 |
| c-Abl modulates tumor cell sensitivity to antibody-dependent cellular cytotoxicity JC Murray, D Aldeghaither, S Wang, RE Nasto, SA Jablonski, Y Tang, ... Cancer immunology research 2 (12), 1186-1198, 2014 | 15 | 2014 |
| Cancer Immunotherapy R Ajina, D Aldeghaither, S Jablonski, LM Weiner Elsevier, 2017 | 3 | 2017 |
| Antibody Therapy BG Smaglo, D Aldeghaither, LM Weiner Immunity to Pathogens and Tumors, 550-559, 2016 | 3 | 2016 |
| Correction: Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B SP Fletcher, DJ Chin, L Gruenbaum, H Bitter, E Rasmussen, P Ravindran, ... Plos Pathogens 12 (3), e1005541, 2016 | 2 | 2016 |
| Alterations of DNA damage response signaling in the development of antibody-dependent cellular cytotoxicity (ADCC) resistance L Weiner, Y Zhang, D Aldeghaither, D Zahavi JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |
| Identifying Molecular Mechanisms of Resistance to Antibody Dependent Cell Mediated Cytotoxicity (ADCC) DS Aldeghaither Georgetown University, 2018 | | 2018 |
| Induction of ADCC resistance profoundly alters tumor cell phenotype and stress response DS Aldeghaither, JC Murray, SM Roth, EJ Fertig, S Tang, SA Jablonski, ... Cancer Research 77 (13_Supplement), 633-633, 2017 | | 2017 |
| Induction of tumor cell-based ADCC resistance to create new tumor cell survival and therapy resistance mechanisms. DS Aldeghaither, JC Murray, SM Roth, EJ Fertig, S Tang, SA Jablonski, ... Journal of Clinical Oncology 35 (7_suppl), 130-130, 2017 | | 2017 |
